Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3708653011 | Product containing atropine and pralidoxime in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3708654017 | Atropine- and pralidoxime-containing product in parenteral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing atropine and pralidoxime in parenteral dose form (medicinal product form) | Is a | Product containing atropine in parenteral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing atropine and pralidoxime in parenteral dose form (medicinal product form) | Has active ingredient | Pralidoxime | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing atropine and pralidoxime in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing atropine and pralidoxime in parenteral dose form (medicinal product form) | Has active ingredient | Atropine | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing atropine and pralidoxime in parenteral dose form (medicinal product form) | Is a | Product containing atropine and pralidoxime | true | Inferred relationship | Existential restriction modifier | ||
Product containing atropine and pralidoxime in parenteral dose form (medicinal product form) | Is a | Product containing pralidoxime in parenteral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Atropine 2.1mg/pralidoxime 600mg single auto-injector solution | Is a | False | Product containing atropine and pralidoxime in parenteral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
Product containing only atropine and pralidoxime in parenteral dose form (medicinal product form) | Is a | True | Product containing atropine and pralidoxime in parenteral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets